| Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours A Mansurov, J Ishihara, P Hosseinchi, L Potin, TM Marchell, A Ishihara, ... Nature biomedical engineering 4 (5), 531-543, 2020 | 157 | 2020 |
| Targeted antibody and cytokine cancer immunotherapies through collagen affinity J Ishihara, A Ishihara, K Sasaki, SSY Lee, JM Williford, M Yasui, H Abe, ... Science translational medicine 11 (487), eaau3259, 2019 | 154 | 2019 |
| Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy JM Williford, J Ishihara, A Ishihara, A Mansurov, P Hosseinchi, ... Science advances 5 (12), eaay1357, 2019 | 107 | 2019 |
| Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy K Sasaki, J Ishihara, A Ishihara, R Miura, A Mansurov, K Fukunaga, ... Science advances 5 (8), eaaw6081, 2019 | 74 | 2019 |
| Bacterial adhesion to ultrafiltration membranes: role of hydrophilicity, natural organic matter, and cell-surface macromolecules S BinAhmed, A Hasane, Z Wang, A Mansurov, ... Environmental science & technology 52 (1), 162-172, 2018 | 73 | 2018 |
| Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies K Katsumata, J Ishihara, A Mansurov, A Ishihara, MM Raczy, E Yuba, ... Science advances 5 (11), eaay1971, 2019 | 55 | 2019 |
| Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker A Mansurov, P Hosseinchi, K Chang, AL Lauterbach, LT Gray, AT Alpar, ... Nature Biomedical Engineering 6 (7), 819-829, 2022 | 41 | 2022 |
| Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis A Ishihara, J Ishihara, EA Watkins, AC Tremain, M Nguyen, A Solanki, ... Nature Biomedical Engineering 5 (5), 387-398, 2021 | 29 | 2021 |
| Polymersomes decorated with the SARS-CoV-2 spike protein receptor-binding domain elicit robust humoral and cellular immunity LR Volpatti, RP Wallace, S Cao, MM Raczy, R Wang, LT Gray, AT Alpar, ... ACS central science 7 (8), 1368-1380, 2021 | 28 | 2021 |
| Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant LT Gray, MM Raczy, PS Briquez, TM Marchell, AT Alpar, RP Wallace, ... Biomaterials 278, 121159, 2021 | 22 | 2021 |
| Immunoengineering approaches for cytokine therapy A Mansurov, A Lauterbach, E Budina, AT Alpar, JA Hubbell, J Ishihara American Journal of Physiology-Cell Physiology 321 (2), C369-C383, 2021 | 21 | 2021 |
| Suppression of rheumatoid arthritis by enhanced lymph node trafficking of engineered interleukin‐10 in murine models E Yuba, E Budina, K Katsumata, A Ishihara, A Mansurov, AT Alpar, ... Arthritis & Rheumatology 73 (5), 769-778, 2021 | 18 | 2021 |
| Tumor cell-surface binding of immune stimulating polymeric glyco-adjuvant via cysteine-reactive pyridyl disulfide promotes antitumor immunity AJ Slezak, A Mansurov, MM Raczy, K Chang, AT Alpar, AL Lauterbach, ... ACS Central Science 8 (10), 1435-1446, 2022 | 14 | 2022 |
| Enhanced lymph node trafficking of engineered IL-10 suppresses rheumatoid arthritis in murine models E Yuba, E Budina, K Katsumata, A Ishihara, A Mansurov, AT Alpar, ... Arthritis & Rheumatology 73, 769, 2021 | 2 | 2021 |
| Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis (Oct, 10.1038/s41551-020-00627-3, 2020) A Ishihara, J Ishihara, EA Watkins, AC Tremain, M Nguyen, A Solanki, ... NATURE BIOMEDICAL ENGINEERING 4 (11), 1117-1117, 2020 | 2 | 2020 |
| Therapeutic synthetic and natural materials for immunoengineering A Slezak, K Chang, S Hossainy, A Mansurov, SJ Rowan, JA Hubbell, ... Chemical Society Reviews, 2024 | 1 | 2024 |
| Methods and compositions for treating inflammatory and autoimmune conditions with ecm-affinity peptides linked to anti-inflammatory agents JA Hubbell, K Katsumata, A Ishihara, J Ishihara, A Mansurov | 1 | 2020 |
| Development and validation of a novel organotypic in vitro model of the tumor-lymph-immune interface for predicting immunotherapy resistance R Zhou, R Weathered, T Kurtanich, R Mezyk-Kopec, A Mansurov, ... CANCER RESEARCH 80 (11), 68-68, 2020 | 1 | 2020 |
| Matrix-binding IL-12 enhances tumor inflammation and drives complete remission in established cold murine tumors A Mansurov, J Hubbell, J Ishihara Journal For Immunotherapy of Cancer 7, 2019 | 1 | 2019 |
| Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia AJ Slezak, K Chang, TN Beckman, KC Refvik, AT Alpar, AL Lauterbach, ... Blood Advances, bloodadvances. 2023012529, 2024 | | 2024 |
Jeffrey HubbellUniversity of ChicagoVerified email at uchicago.edu
